Molecular profiling has transformed cancer care, but 30% of high-risk pediatric cancers do not have actionable therapeutic targets, limiting personalized treatment options and negatively affecting ...

After the DNA sequence of the boy’s genome showed a mutation in the VMA21 gene, one of the known causes of XMEA, University of Alabama at Birmingham and Children’s of Alabama pediatric neurologist ...

Dr. Jason Berman looking at a zebrafish model on the computer screen. New research shows that pre-clinical zebrafish models are an effective tool to help guide clinical decision-making in real time ...

BIRMINGHAM, Ala. – Can a small fish help identify possible treatments for an ultra-rare inherited disease found in an Alabama boy? The genetic disease is XMEA, which progressively weakens the muscles ...